Biotimize – Biotechnology as a Service (BTaaS)
Is this your company? Claim this profile
Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
Biotimize – Biotechnology as a Service (BTaaS) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Respiratory
Allergy
Quick Facts
HQ:Brazil
Founded:2000
Employees:525
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Sterile Injectable
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval OC9EZ7
Health Canada · #APR-GKBTX45W · 2019-07-01
Drug Approval 2XK3JF
EMA · #APR-Y042V26G · 2021-01-01
Certifications
WHO GMP
World Health Organization
Cert #: CERT-TWKHDU5E
Issued: 2020-03-05
Expires: 2025-09-14
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-ODYZ588L
Issued: 2020-11-25
Expires: 2025-02-08
Health Canada GMP
Health Canada
Cert #: CERT-YO1W9IN6
Issued: 2020-03-28
Expires: 2025-09-02
Loading CDMO intelligence...
Key facts about Biotimize – Biotechnology as a Service (BTaaS)
- Biotimize – Biotechnology as a Service (BTaaS) is headquartered in Brazil.
- Biotimize – Biotechnology as a Service (BTaaS) was founded in 2000.
- Biotimize – Biotechnology as a Service (BTaaS) has 525 employees.
- Biotimize – Biotechnology as a Service (BTaaS)'s capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.
Find CDMOs like Biotimize – Biotechnology as a Service (BTaaS)
Directory pages this company appears in, each with the full list of matching manufacturers.